Holzer Holzer & Fistel, LLC announces that it is investigating potential breaches of fiduciary duty by certain directors of Illumina Inc. ("Illumina" or the "Company") (NASDAQ: ILMN) in connection with the Company's rejection of Roche Holding AG's offer to purchase all outstanding shares of Illumina for $44.50 per share. On January 26, 2010, Illumina announced that it adopted a "poison pill" whereby Company shareholders could purchase new shares if a bidder acquires 15 percent of its shares making it more difficult to obtain a majority of Company stock.

Holzer Holzer & Fistel, LLC's investigation seeks to determine if Illumina's Board has complied with its fiduciary duty to act in its shareholders best interest in responding to Roche's offer.

If you own shares of Illumina stock and would like to discuss your legal rights, you may contact Michael I. Fistel, Jr., Esq., or Marshall P. Dees, Esq. via email at mfistel@holzerlaw.com, or mdees@holzerlaw.com, or via toll-free telephone at (888) 508-6832.

Holzer Holzer & Fistel, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer Holzer & Fistel, LLC has paid for the dissemination of this promotional communication, and Michael I. Fistel, Jr. is the attorney responsible for its content.

Holzer Holzer & Fistel, LLC
Michael I. Fistel, Jr., Esq., 888-508-6832 (toll-free)
mfistel@holzerlaw.com
or
Marshall P. Dees, Esq., 888-508-6832 (toll-free)
mdees@holzerlaw.com